PubRank

P A Hall

Author PubWeight™ 140.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The p53 pathway. J Pathol 1999 6.79
2 The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 1994 3.28
3 A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 1991 2.71
4 Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med 1990 2.57
5 Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 1991 2.52
6 Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 1993 2.52
7 p53 in tumour pathology: can we trust immunohistochemistry?--Revisited! J Pathol 1994 2.41
8 The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991 2.32
9 Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990 2.29
10 In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993 2.07
11 p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet 1991 1.95
12 The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr Biol 1997 1.86
13 High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A 1997 1.81
14 Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. J Pathol 1987 1.80
15 Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations. Histopathology 1988 1.76
16 Do we really need a higher necropsy rate? Lancet 1999 1.71
17 Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene 1995 1.62
18 Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol 1991 1.58
19 Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci 1995 1.57
20 Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp Cell Res 2001 1.57
21 The complexities of proliferating cell nuclear antigen. Histopathology 1992 1.57
22 Endocrine cells of the human gastrointestinal tract have no proliferative capacity. Histochem J 1995 1.49
23 The epidermal growth factor receptor in human pancreatic cancer. J Pathol 1992 1.47
24 Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 1991 1.46
25 Koch's postulates revisited. J Pathol 1991 1.46
26 The p53 response to ionising radiation in adult and developing murine tissues. Oncogene 1996 1.46
27 Ki67--structure, function, and new antibodies. J Pathol 1992 1.45
28 APC expression in normal human tissues. J Pathol 1997 1.44
29 Comparison of manual data coding errors in two hospitals. J Clin Pathol 1986 1.42
30 Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coagulation assay. J Clin Microbiol 1993 1.41
31 The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology 1993 1.40
32 Identification of the antigen recognized by the monoclonal antibody BU31 as lamins A and C. J Pathol 1996 1.38
33 The p53 tumour suppressor gene. Br J Surg 1998 1.37
34 Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992 1.33
35 New marker of B lymphocytes, MB2: comparison with other lymphocyte subset markers active in conventionally processed tissue sections. J Clin Pathol 1987 1.30
36 Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. Gastroenterology 1992 1.30
37 Expression of the 'dead box' RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus. J Pathol 1998 1.23
38 Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int 1987 1.22
39 Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 2000 1.21
40 Do septins have a role in cancer? Br J Cancer 2005 1.20
41 Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol Oncol 1989 1.18
42 Rapid technique of DNA-DNA in situ hybridisation on formalin fixed tissue sections using microwave irradiation. J Clin Pathol 1987 1.17
43 Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA). Histopathology 1991 1.17
44 The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 2000 1.16
45 MDM2--arbiter of p53's destruction. Trends Biochem Sci 1997 1.15
46 Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation. J Cell Sci 1996 1.14
47 Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues. Am J Pathol 1996 1.12
48 Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease. Histopathology 1989 1.11
49 Enteroendocrine cell hyperplasia, carcinoid tumours and adenocarcinoma in long-standing ulcerative colitis. Histopathology 1986 1.10
50 Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. Lab Invest 1993 1.10
51 Do aggressive subclones within primary colorectal cancer give rise to liver metastases? Int J Colorectal Dis 1989 1.10
52 Enzyme-linked immunosorbent assay and enzyme-linked coagulation assay for detection of Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes with dual-label antibodies. J Clin Microbiol 1994 1.08
53 Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens. Cancer Res 1994 1.08
54 Demonstration of DNA damage/repair in individual cells using in situ end labelling: association of p53 with sites of DNA damage. J Pathol 1995 1.07
55 p53--integrating the complexity. J Pathol 1996 1.06
56 The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol 2000 1.05
57 Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds. Histopathology 1993 1.02
58 Epithelial tumors metastatic to the uterine cervix. A study of 33 cases and review of the literature. Cancer 1986 1.01
59 Proliferative compartment deregulation in the non-neoplastic colonic epithelium of familial adenomatous polyposis. Gut 1995 1.01
60 Antibodies to T cell antigen receptor beta chain families detect monoclonal T cell proliferation. Lancet 1986 1.00
61 Acetone/periodate-lysine-paraformaldehyde (PLP) fixation and improved morphology of cryostat sections for immunohistochemistry. Histopathology 1987 0.94
62 Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res 1993 0.93
63 Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response. J Pathol 2000 0.91
64 The role of the p53 protein in the apoptotic response. Philos Trans R Soc Lond B Biol Sci 1994 0.90
65 Ki67: from antibody to molecule to understanding? Clin Mol Pathol 1995 0.90
66 p53 expression is common in malignant mesothelioma. Histopathology 1992 0.90
67 The biochemical characterization of the DNA binding activity of pKi67. J Pathol 2000 0.88
68 Control of differentiation in a rectal adenocarcinoma cell line: the role of diffusable and cell-associated factors. J Pathol 1991 0.88
69 Biochemical characterization of pKi67 with the identification of a mitotic-specific form associated with hyperphosphorylation and altered DNA binding. Exp Cell Res 1999 0.87
70 Fen1 expression: a novel marker for cell proliferation. J Pathol 1998 0.87
71 A nude mouse xenograft model of fetal intestine development and differentiation. Development 1992 0.86
72 Classification of primary gut lymphomas. Lancet 1988 0.85
73 The Trp53 pathway is induced in vivo by low doses of gamma radiation. Radiat Res 2001 0.85
74 Extraction of DNA from small sections of frozen tissue with simultaneous histological examination. J Clin Pathol 1988 0.85
75 Does the p53 up-regulated Gadd45 protein have a role in excision repair? Science 1995 0.84
76 Malignant lymphoma with eosinophilia of the gastrointestinal tract. Histopathology 1987 0.83
77 Growth factors and oncogenes in pancreatic cancer. Baillieres Clin Gastroenterol 1990 0.83
78 Why is p53 protein stabilized in neoplasia? Some answers but many more questions? J Pathol 1998 0.83
79 A functional model of adult human prostate epithelium. The role of androgens and stroma in architectural organisation and the maintenance of differentiated secretory function. J Cell Sci 1992 0.83
80 The immunocytochemical detection of p53 protein in cytological specimens: technical considerations. Cytopathology 1994 0.82
81 Proliferating cell nuclear antigen immunolocalization in gastro-intestinal epithelia. Digestion 1991 0.82
82 Simultaneous presentation of T- and B-cell malignant lymphoma with bcl-2 gene involvement. Blood 1989 0.82
83 The association between cell proliferation and apoptosis: studies using the cell cycle-associated proteins Ki67 and DNA polymerase alpha. J Pathol 1996 0.81
84 An immunochemical analysis of mdm2 expression in human breast cancer and the identification of a growth-regulated cross-reacting species p170. J Pathol 1998 0.81
85 The yeast two-hybrid system for identifying protein-protein interactions. J Pathol 2003 0.80
86 Management of localized non-Hodgkin's lymphoma: the experience at St. Bartholomew's Hospital 1972-1985. Hematol Oncol 1989 0.79
87 The p53 tumour suppressor gene and tumour prognosis: is there a relationship? J Pathol 1995 0.79
88 Molecular and cellular themes in inflammation and immunology. J Pathol 2008 0.79
89 Overview of the fibroblast growth factor and receptor families: complexity, functional diversity, and implications for future cardiovascular research. Cardiovasc Res 1993 0.79
90 Tumour diagnosis. Nature 1994 0.79
91 Expression of the nuclear membrane protein statin in cycling cells. J Pathol 1993 0.78
92 The clinical relevance of the p53 tumour suppressor gene. Cytopathology 1994 0.78
93 Epithelial-mesenchymal interactions can influence the phenotype of carcinoma metastases in the mucosa of the intestine. J Pathol 1990 0.78
94 Gadd45 mutations are uncommon in human tumour cell lines. Cell Prolif 2000 0.78
95 A monoclonal antibody (anti-L-35) which reacts with human osteoclasts and cells of the mononuclear phagocyte system. Br J Exp Pathol 1988 0.78
96 Measuring a cell's response to stress: the p53 pathway. Genome Biol 2000 0.77
97 Analysis of apoptosis in tissue sections. Methods Mol Biol 2001 0.77
98 Modeling the growth of Listeria monocytogenes in cured ready-to-eat processed meat products by manipulation of sodium chloride, sodium diacetate, potassium lactate, and product moisture content. J Food Prot 2002 0.77
99 The fibroblast growth factor and receptor multigene families. J Pathol 1993 0.77
100 Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology. J Clin Pathol 1993 0.77
101 Food safety objective approach for controlling Clostridium botulinum growth and toxin production in commercially sterile foods. J Food Prot 2011 0.77
102 Cytokeratin and laminin immunostaining in the diagnosis of cutaneous neuro-endocrine (Merkel cell) tumours. Histopathology 1986 0.77
103 The gut-associated lymphoid tissue and its tumours. Curr Top Pathol 1990 0.77
104 Challenges to improving health risk communication in the 21st century: a discussion. J Natl Cancer Inst Monogr 1999 0.77
105 Autonomic hyperreflexia in spinal cord injured patients: trigger mechanism--dressing changes of pressure sores. J Trauma 1983 0.77
106 Expression of p21waf1/Cip1, MDM2 and p53 in vivo: analysis of cytological preparations. Cytopathology 1996 0.76
107 Lysophospholipase activity of Ascaris suum-induced mouse peritoneal neutrophils and eosinophils. Microb Pathog 1991 0.76
108 Lymphoplasmacytoid and small cell centrocytic non-Hodgkin's lymphoma--a retrospective analysis from St Bartholomew's Hospital 1972-1986. Hematol Oncol 1989 0.76
109 Proliferative activity in Reed-Sternberg cells. Histopathology 1994 0.76
110 Field change, clonality, and early epithelial cancer: possible lessons from p53. J Pathol 1997 0.75
111 Cell proliferation in pathology. J Pathol 1993 0.75
112 Differential diagnosis of metastatic undifferentiated carcinoma. J Clin Pathol 1989 0.75
113 A Review of Injuries to the Vertebrae occurring in the Royal Air Force. Br Med J 1940 0.75
114 Immunohistochemistry in lymphoma diagnosis. Br Med J (Clin Res Ed) 1986 0.75
115 Keratin expression in human tissues and neoplasms: other issues. Histopathology 2003 0.75
116 Assessment of follicular lymphomas. J Pathol 1989 0.75
117 Of spots, stripes and muddled thinking! Histopathology 1993 0.75
118 Angiolymphoid hyperplasia with eosinophilia. J R Soc Med 1987 0.75
119 Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 2002 0.75
120 The assessment of proliferating cell nuclear antigen (PCNA)immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis. Histopathology 2002 0.75
121 Simultaneous presentation of B- and T-cell malignant lymphoma. Haematol Blood Transfus 1989 0.75
122 14;18 translocation in primary intestinal lymphoma: detection by polymerase chain reaction in routinely processed tissue. Histopathology 1991 0.75
123 Analysis of apoptosis in tissue sections. Methods Mol Med 1999 0.75
124 Effects of altered cardiac ventricular chamber size on the electrocardiogram and position of the heart. Am J Cardiol 1990 0.75
125 An inter-observer and intra-observer variability study on the diagnosis of lymph node biopsy specimens. Eur J Cancer 1992 0.75
126 Paediatric triple lumen catheter. Paediatr Anaesth 1995 0.75
127 Proliferating trichilemmal cyst occurring on the shin. J Cutan Pathol 1986 0.75
128 Expression of p53 in reactive mesothelium. Histopathology 1993 0.75
129 The challenge of p53: linking biochemistry, biology, and patient management. Stem Cells 1998 0.75
130 Caecal lipomas mimicking colonic angiodysplasia. Br J Radiol 1985 0.75
131 Plastic embedding of bone marrow biopsies. Histopathology 1987 0.75
132 Multicentric reticulohistiocytosis. Detailed immunophenotyping confirms macrophage origin. Am J Surg Pathol 1990 0.75
133 Unification of electromagnetic effects in human retinal receptors with three pigment colour vision. Nature 1969 0.75
134 Histiocytosis X mimicking recurrent malignant disease: a report of two cases. Clin Radiol 1988 0.75
135 Classifying primary gut lymphomas. Lancet 1988 0.75
136 Modified excised teat model for laboratory screening of teat dips. J Dairy Sci 1981 0.75
137 Carcinoma of the gall bladder metastatic to the cervix. Case report. Br J Obstet Gynaecol 1986 0.75
138 Langerhan's cell histiocytosis: an unusual case illustrating the value of immunohistochemistry in diagnosis. Histopathology 1988 0.75
139 Effects of an aromatase inhibitor on thymus and kidney and on oestrogen receptors in female MRL/MP-lpr/lpr mice. Lupus 1993 0.75